Sleep Improvement Therapy Affects Pregnancy Outcomes in Chinese Singletons and Twins by Improving Sleep Quality

Condition(s) studied

Investigational drug(s) / intervention(s)

Sleep restriction: Go to bed before 23pm

Stimulation control: Avoid drugs, alcohol, caffeine, and nicotine

Cognitive therapy: Listen to 30 minutes of soothing music every night for 8 weeks

Sleep principles discussion: The principles of sleep hygiene are discussed, but without the application of stimulus control or sleep restriction

Study summary

During pregnancy, the physical and psychological changes of pregnant women, hyperemesis gravidarum, uterine compression, frequent urination, hip or pelvic pain, back pain, leg cramps, gastroesophageal reflux, changes in mental state, and even changes in lifestyle, habits and tastes may affect the sleep of pregnant women. Due to the coexistence of physiological, psychological, social and other complex factors during pregnancy, the incidence of sleep disorders in pregnant women is relatively high, up to 50%, and shows an increasing trend with the increase of gestational week. Not only seriously affect the quality of life of pregnant women, but also may lead to a variety of pregnancy complications, and even lead to adverse pregnancy outcomes. Therefore, early identification, timely diagnosis and treatment of sleep disorders during pregnancy are important measures to improve or even reverse adverse pregnancy outcomes. Although sleep disorders are more common and seriously harmful during pregnancy, people lack of understanding and attention to such diseases, and often regard them as normal clinical manifestations of pregnancy and neglect diagnosis and treatment.

Studies have shown that maternal sleep disorders are associated with hypertensive disorders during pregnancy, preterm birth, and gestational diabetes. Current research objects mainly focus on single pregnancy, twin related research is less.

The purpose of this study is to explore the perinatal sleep health of pregnant women with twin pregnancies, reduce the complications of pregnant women with twin pregnancies and improve the pregnancy outcomes of mothers and infants by improving sleep quality.

Eligibility

Primary outcome measure(s)

• Hypertension in pregnancy — From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)
  Pregnancy induced hypertension (PIH) is hypertension that occurs after 20 weeks of gestation in women with previously normal blood pressure.
• Gestational diabetes mellitus — From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)
  Gestational diabetes mellitus (GDM) is defined as glucose intolerance of variable degree with onset or first recognition during pregnancy
• Preterm labor — From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)
  Preterm labor is parturition that occurs when birth occurs between 28 weeks of gestation and 37 weeks
• NICU infants — From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)
  Neonatal NICU occupancy rate

Trial sites (1)

Other trials for the same condition